Go Pro
→ Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (From InvestorPlace) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
DexCom, Inc. stock logo
DXCM
DexCom
$88.98
-0.4%		$84.10
$54.11
▼
$92.59
$33.54B1.425.13 million shs227,231 shs
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$28.39
+1.4%		$30.06
$13.74
▼
$65.30
$6.60B2.4224.26 million shs1.62 million shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
DexCom, Inc. stock logo
DXCM
DexCom
0.00%+7.61%-3.24%+29.36%+32.47%
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
0.00%+2.04%-16.83%-16.65%-51.50%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
DexCom, Inc. stock logo
DXCM
DexCom
$88.98
-0.4%		$84.10
$54.11
▼
$92.59
$33.54B1.425.13 million shs227,231 shs
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$28.39
+1.4%		$30.06
$13.74
▼
$65.30
$6.60B2.4224.26 million shs1.62 million shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
DexCom, Inc. stock logo
DXCM
DexCom
0.00%+7.61%-3.24%+29.36%+32.47%
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
0.00%+2.04%-16.83%-16.65%-51.50%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
DexCom, Inc. stock logo
DXCM
DexCom
2.92
Moderate Buy$89.080.12% Upside
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
2.13
Hold$32.4314.26% Upside

Current Analyst Ratings Breakdown

Latest DXCM and HIMS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/18/2026
DexCom, Inc. stock logo
DXCM
DexCom
Truist Financial Corporation logo
Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price TargetBuy$93.00 ➝ $102.00
9/18/2026
DexCom, Inc. stock logo
DXCM
DexCom
TD Cowen logo
TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$95.00
9/11/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
JPMorgan Chase & Co. logo
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageNeutral$32.00
8/24/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Truist Financial Corporation logo
Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetHold$27.00 ➝ $32.00
8/21/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Barclays PLC logo
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOverweight$39.00 ➝ $35.00
8/11/2026
DexCom, Inc. stock logo
DXCM
DexCom
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold (C-) ➝ Hold (C)
8/11/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Deutsche Bank Aktiengesellschaft logo
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetHold$25.00 ➝ $26.00
8/11/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
TD Cowen logo
TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetHold$25.00 ➝ $30.00
8/11/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Morgan Stanley logo
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetEqual Weight$21.00 ➝ $28.00
8/11/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetNeutral$35.00 ➝ $33.00
8/11/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Bank of America Corporation logo
Bank of America
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$30.00 ➝ $32.00
(Data available from 9/21/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
DexCom, Inc. stock logo
DXCM
DexCom
$4.97B6.76$2.76 per share32.27$7.04 per share12.64
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$2.58B2.57$0.85 per share33.44$2.38 per share11.93
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
DexCom, Inc. stock logo
DXCM
DexCom
$836.30M$2.5335.1328.891.5020.12%35.94%14.75%10/29/2026 (Estimated)
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$128.37M-$0.63N/A64.51N/A-5.51%-6.51%-1.20%11/9/2026 (Estimated)

Latest DXCM and HIMS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/10/2026Q2 2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
-$0.0498-$0.37-$0.3202-$0.37$698.90 million$753.21 million
7/30/2026Q2 2026
DexCom, Inc. stock logo
DXCM
DexCom
$0.6110$0.70+$0.0890$0.64$1.29 billion$1.31 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
DexCom, Inc. stock logo
DXCM
DexCom
N/AN/AN/AN/AN/A
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
DexCom, Inc. stock logo
DXCM
DexCom
0.47
1.73
1.43
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
4.21
0.93
0.87

Institutional Ownership

CompanyInstitutional Ownership
DexCom, Inc. stock logo
DXCM
DexCom
97.75%
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
63.52%

Insider Ownership

CompanyInsider Ownership
DexCom, Inc. stock logo
DXCM
DexCom
0.28%
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
11.76%
CompanyEmployeesShares OutstandingFree FloatOptionable
DexCom, Inc. stock logo
DXCM
DexCom
11,000377.36 million376.30 millionOptionable
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
2,442233.31 million205.88 millionOptionable

Recent News About These Companies

Investors Heavily Search Hims & Hers Health, Inc. (HIMS): Here is What You Need to Know
 |  zacks.comhttps://www.zacks.com/stock/news/2992781/investors-heavily-search-hims-hers-health-inc-hims-here-is-what-you-need-to-know?cid=cs-stocknewsapi-ft-fundamental_analysis|most_searched_stocks-2992781
HIMS INVESTOR DEADLINE: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces - November 2, 2026 Deadline
 |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/21/3365400/0/en/hims-investor-deadline-hims-hers-health-inc-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-robbins-geller-rudman-dowd-llp-announces-november-2-2026.html
Hims & Hers Health (NYSE:HIMS) CFO Sells $354,860.66 in Stock
September 21 at 4:22 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31036448
ROSEN, A LEADING LAW FIRM, Encourages Hims & Hers Health, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - HIMS
September 19 at 12:44 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/20/3365062/673/en/rosen-a-leading-law-firm-encourages-hims-hers-health-inc-investors-with-losses-in-excess-of-100k-to-secure-counsel-before-important-deadline-in-securities-class-action-hims.html
Hims & Hers Health, Inc. Class Action Lawsuit Seeks Recovery for Investors; November 2, 2026, Deadline - Contact Kessler Topaz Meltzer & Check, LLP
September 19 at 7:08 PM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/19/3365048/0/en/hims-hers-health-inc-class-action-lawsuit-seeks-recovery-for-investors-november-2-2026-deadline-contact-kessler-topaz-meltzer-check-llp.html
Hims & Hers Chief Legal Officer Soleil Boughton Sells 6,236 Shares
September 19 at 9:55 AM  |  fool.comhttps://www.fool.com/coverage/filings/2026/09/19/hims-hers-chief-legal-officer-soleil-boughton-sells-6236-shares/
HIMS INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Hims Investors of Securities Class Action Lawsuit Deadline on November 2, 2026
September 19 at 7:56 AM  |  newsfilecorp.comN
Kaplan Fox Alerts Hims & Hers Health, Inc. (NYSE: HIMS) Investors to Seek Leadership in a Securities Fraud Lawsuit by November 2, 2026
September 19 at 7:32 AM  |  newmediawire.comN
Hims & Hers Health (NYSE:HIMS) CFO Sells 12,313 Shares
September 19 at 6:52 AM  |  insidertrades.comhttps://www.insidertrades.com/alerts/nyse-hims-insider-buying-and-selling-2026-09-19/
Hims & Hers Health Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Hims & Hers Health, Inc. - HIMS
September 18 at 10:00 PM  |  prnewswire.comhttps://www.prnewswire.com/news-releases/hims--hers-health-shareholder-alert-claimsfiler-reminds-investors-with-losses-in-excess-of-100-000-of-lead-plaintiff-deadline-in-class-action-lawsuit-against-hims--hers-health-inc---hims-302883660.html
Hims & Hers Health (NYSE: HIMS) Chief Legal Officer Sells 6,236 Shares at $27.86 Each
September 18 at 8:15 PM  |  kalkinemedia.comK
Robbins LLP Urges HIMS Stockholders Who Lost Money Investing in Hims & Hers Health, Inc. to Contact the Firm for Information About Leading the Class Action
September 18 at 5:50 PM  |  businesswire.comhttps://www.businesswire.com/news/home/20260918493031/en/robbins-llp-urges-hims-stockholders-who-lost-money-investing-in-hims-hers-health-inc.-to-contact-the-firm-for-information-about-leading-the-class-action/
Insider Selling: Hims & Hers Health (NYSE:HIMS) CFO Sells 12,313 Shares
September 18 at 5:07 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-insider-selling-hims-hers-health-nyse-hims-cfo-sells-12313-shares-2026-09-18/
Kaplan Fox Reminds Hims & Hers Health, Inc. (HIMS) Investors to Seek a Leadership Role Before Deadline on November 2, 2026
September 18 at 5:00 PM  |  newsfilecorp.comN
Hims & Hers Health (NYSE: HIMS) Faces Securities Class Action After FTC Lawsuit Reveal Drives Stock Sharply Lower -- HBSS
September 18 at 3:18 PM  |  newsfilecorp.comN
Hims & Hers Health, Inc. (HIMS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
September 18 at 1:25 PM  |  prnewswire.comhttps://www.prnewswire.com/news-releases/hims--hers-health-inc-hims-shareholders-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-302882456.html
Kaplan Fox Reminds Hims & Hers Health, Inc. (NYSE: HIMS) Investors of a Securities Class Action Deadline on November 2, 2026
September 18 at 11:30 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/18/3364833/1020/en/kaplan-fox-reminds-hims-hers-health-inc-nyse-hims-investors-of-a-securities-class-action-deadline-on-november-2-2026.html
Kaplan Fox & Kilsheimer LLP Alerts Hims & Hers Health, Inc. (NYSE: HIMS) Investors to the Lead Plaintiff Deadline on November 2, 2026
September 18 at 10:08 AM  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/markets-news/NewMediaWire/4670704/kaplan-fox-kilsheimer-llp-alerts-hims-hers-health-inc-nyse-hims-investors-to-the-lead-plaintiff-deadline-on-november-2-2026/
Shareholders who lost money in shares of acquired Hims & Hers Health, Inc. (NYSE: HIMS) should contact Wolf Haldenstein Immediately
September 18 at 8:01 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/18/3364671/6819/en/shareholders-who-lost-money-in-shares-of-acquired-hims-hers-health-inc-nyse-hims-should-contact-wolf-haldenstein-immediately.html
Soleil Boughton Sells 6,236 Shares of Hims & Hers Health (NYSE:HIMS) Stock
September 18 at 7:22 AM  |  insidertrades.comhttps://www.insidertrades.com/alerts/nyse-hims-insider-buying-and-selling-2026-09-18/
Baird Financial Group Inc. Raises Holdings in Hims & Hers Health, Inc. $HIMS
September 18 at 3:04 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-baird-financial-group-inc-raises-holdings-in-hims-hers-health-inc-hims-2026-09-18/

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Data center hallway with rows of server racks and cables, plus a monitoring room with computer screens in the background.
AI Token Costs Are Changing the Hardware vs. Software Debate
By Jeffrey Neal Johnson | September 6, 2026
NVIDIA logo over a computer chip, server racks, and an upward-trending green stock price chart.
NVIDIA’s Blockbuster Quarter May Still Undersell How Big the AI Buildout Is
By Thomas Hughes | August 27, 2026
Illustration of a computer chip on a circuit board with an upward green stock chart line in a server room.
Securing AI: 5 Most-Upgraded Stocks From the Q2 Reporting Season
By Thomas Hughes | August 31, 2026
A Tesla concept vehicle with illuminated front light bar drives on a road against a city skyline at dusk.
Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected
By Sam Quirke | September 8, 2026
Illustration showing Hims & Hers logo and app connected through a security checkpoint icon to the Visa logo and card.
Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
By Jeffrey Neal Johnson | August 24, 2026
DexCom stock logo

DexCom NASDAQ:DXCM

$88.98 -0.37 (-0.42%)
As of 10:26 AM Eastern
This is a fair market value price provided by Massive. Learn more.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

Hims & Hers Health stock logo

Hims & Hers Health NYSE:HIMS

$28.38 +0.40 (+1.41%)
As of 10:26 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas